e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis
Li Li, Silveira Lori J., Hamzeh Nabeel, Gillespie May, Mroz Peggy M., Mayer Annyce S., Fingerlin Tasha E., Maier Lisa A.
Source:
Eur Respir J 2016; 47:1797-1808
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Li Li, Silveira Lori J., Hamzeh Nabeel, Gillespie May, Mroz Peggy M., Mayer Annyce S., Fingerlin Tasha E., Maier Lisa A.. Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis. Eur Respir J 2016; 47:1797-1808
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Differential gene expression of lung fibroblasts derived from UIP and NSIP patterns of interstitial lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002
Pleural and systemic cytokine expression profiles in patients with lung cancer
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Differential expression of let-7d in different types of idiopathic fibrotic lung disease
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
The expression of antioxidants in small airways in COPD is increased, heterogeneous and correlates with local histopathological alterations
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Distinct epithelial phenotypes in child allergic respiratory disease are revealed by gene expression profiling
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
BAL protein profiles specific of different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Increased cytokeratin-19 expression in fibrotic interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002
Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity
Source: Eur Respir J 2001; 18: Suppl. 33, 410s
Year: 2001
Endobronchial biopsy gene expression between different severe asthma inflammatory phenotypes
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests
Source: Eur Respir J 2002; 20: Suppl. 38, 106s
Year: 2002
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Collagen1a1 mRNA expression in BAL cells is associated with disease progression and poor survival in ILDs
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
αVβ6 integrin expression in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept